219 related articles for article (PubMed ID: 13413145)
1. The inhibitory action of some antimalarial drugs and related compounds on the hexokinase of yeast and of Plasmodium berghei.
FRASER DM; KERMACK WO
Br J Pharmacol Chemother; 1957 Mar; 12(1):16-23. PubMed ID: 13413145
[TBL] [Abstract][Full Text] [Related]
2. Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
Skinner-Adams TS; Fisher GM; Riches AG; Hutt OE; Jarvis KE; Wilson T; von Itzstein M; Chopra P; Antonova-Koch Y; Meister S; Winzeler EA; Clarke M; Fidock DA; Burrows JN; Ryan JH; Andrews KT
Commun Biol; 2019; 2():166. PubMed ID: 31069275
[TBL] [Abstract][Full Text] [Related]
3. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
Konziase B
J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
[TBL] [Abstract][Full Text] [Related]
4. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the antimalarial activity of new compounds against Plasmodium falciparum in vitro, and Plasmodium berghei in vivo.
Tedlaouti F; Gasquet M; Delmas F; Timon-David P; Madadi NE; Vanelle P; Maldonado J
J Pharm Belg; 1990; 45(5):306-10. PubMed ID: 2086754
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the ex vivo antimalarial activity of organotin (IV) ethylphenyldithiocarbamate on erythrocytes infected with Plasmodium berghei NK 65.
Awang N; Jumat H; Ishak SA; Kamaludin NF
Pak J Biol Sci; 2014 Jun; 17(6):836-42. PubMed ID: 26035957
[TBL] [Abstract][Full Text] [Related]
7. The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine.
Enosse S; Butcher GA; Margos G; Mendoza J; Sinden RE; Høgh B
Trans R Soc Trop Med Hyg; 2000; 94(1):77-82. PubMed ID: 10748906
[TBL] [Abstract][Full Text] [Related]
8. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Effect on
Sawant SS; Gabhe SY; Singh KK
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513343
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial activity of Floxacrine (HOE 991) I. Studies on blood schizontocidal action of Floxacrine against Plasmodium berghei, P. vinckei and P. cynomolgi.
Raether W; Fink E
Ann Trop Med Parasitol; 1979 Dec; 73(6):505-26. PubMed ID: 120142
[TBL] [Abstract][Full Text] [Related]
12. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
[TBL] [Abstract][Full Text] [Related]
13. The novel oxygenated chalcone, 2,4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo.
Chen M; Brøgger Christensen S; Zhai L; Rasmussen MH; Theander TG; Frøkjaer S; Steffansen B; Davidsen J; Kharazmi A
J Infect Dis; 1997 Nov; 176(5):1327-33. PubMed ID: 9359735
[TBL] [Abstract][Full Text] [Related]
14. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
[TBL] [Abstract][Full Text] [Related]
15. Metabolites of febrifugine and its synthetic analogue by mouse liver S9 and their antimalarial activity against Plasmodium malaria parasite.
Hirai S; Kikuchi H; Kim HS; Begum K; Wataya Y; Tasaka H; Miyazawa Y; Yamamoto K; Oshima Y
J Med Chem; 2003 Sep; 46(20):4351-9. PubMed ID: 13678413
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial activity of a 4',5'-unsaturated 5'-fluoroadenosine mechanism-based inhibitor of S-adenosyl-L-homocysteine hydrolase.
Bitonti AJ; Baumann RJ; Jarvi ET; McCarthy JR; McCann PP
Biochem Pharmacol; 1990 Aug; 40(3):601-6. PubMed ID: 2200410
[TBL] [Abstract][Full Text] [Related]
17. Substrate and Inhibitor Specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1.
Arora A; Deniskin R; Sosa Y; Nishtala SN; Henrich PP; Kumar TR; Fidock DA; Akabas MH
Mol Pharmacol; 2016 Jun; 89(6):678-85. PubMed ID: 27048953
[TBL] [Abstract][Full Text] [Related]
18. Cysteine-stabilised peptide extract of Morinda lucida (Benth) leaf exhibits antimalarial activity and augments antioxidant defense system in P. berghei-infected mice.
Adebayo JO; Adewole KE; Krettli AU
J Ethnopharmacol; 2017 Jul; 207():118-128. PubMed ID: 28645782
[TBL] [Abstract][Full Text] [Related]
19. Isolation and identification of carotenoid-producing yeast and evaluation of antimalarial activity of the extracted carotenoid(s) against P. falciparum.
Sinha S; Chakrabarti A; Singh G; Kumar KK; Gaur NA; Arora A; Singh KN; Singh S; Paul D
Biol Futur; 2021 Sep; 72(3):325-337. PubMed ID: 34554551
[TBL] [Abstract][Full Text] [Related]
20. Improved efficacy of doxycycline in liposomes against Plasmodium falciparum in culture and Plasmodium berghei infection in mice.
Rajendran V; Singh C; Ghosh PC
Can J Physiol Pharmacol; 2018 Nov; 96(11):1145-1152. PubMed ID: 30075085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
